TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 34 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,953 | -16.3% | 213,223 | +36.8% | 0.00% | – |
| Q2 2023 | $45,345 | -84.6% | 155,826 | 0.0% | 0.00% | – |
| Q1 2023 | $294,511 | +126844.4% | 155,826 | 0.0% | 0.00% | – |
| Q4 2022 | $232 | -99.9% | 155,826 | -0.2% | 0.00% | – |
| Q3 2022 | $260,000 | -16.7% | 156,158 | 0.0% | 0.00% | – |
| Q2 2022 | $312,000 | -22.4% | 156,158 | +2.0% | 0.00% | – |
| Q1 2022 | $402,000 | +1.0% | 153,060 | +6.4% | 0.00% | – |
| Q4 2021 | $398,000 | -29.4% | 143,912 | -1.3% | 0.00% | – |
| Q3 2021 | $564,000 | -36.9% | 145,745 | +5.7% | 0.00% | – |
| Q2 2021 | $894,000 | +3.6% | 137,822 | +31.3% | 0.00% | – |
| Q1 2021 | $863,000 | +7.5% | 104,954 | +52.8% | 0.00% | – |
| Q4 2020 | $803,000 | – | 68,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $9,004,920 | 2.70% |
| Ikarian Capital, LLC | 2,765,530 | $5,226,851 | 1.19% |
| JOHNSON & JOHNSON | 84,003 | $158,766 | 0.05% |
| X-Square Capital, LLC | 17,743 | $34 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $489,215 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $859,791 | 0.01% |
| HoyleCohen, LLC | 13,000 | $24,570 | 0.00% |
| MGO ONE SEVEN LLC | 11,780 | $22,264 | 0.00% |
| Bank of New York Mellon Corp | 66,606 | $125,885 | 0.00% |
| Citadel Advisors | 24,700 | $46,683 | 0.00% |